LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 89.57 | 84.90 | 5668 | 7494 | 0.7563 | 0.9154 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 89.57 | 84.90 | 518 | 7494 | 0.0691 | 0.3229 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 89.57 | 84.90 | 10743 | 7494 | 1.4334 | 1.1146 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 91.27 | 84.90 | 3 | 7420 | 0.0004 | -0.4045 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 91.27 | 84.90 | 5422 | 7420 | 0.7307 | 0.9050 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 91.27 | 84.90 | 519 | 7420 | 0.0699 | 0.3241 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 91.27 | 84.90 | 11120 | 7420 | 1.4986 | 1.1295 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 92.98 | 84.90 | 2 | 7257 | 0.0003 | -0.4424 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 92.98 | 84.90 | 5411 | 7257 | 0.7456 | 0.9106 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 92.98 | 84.90 | 526 | 7257 | 0.0725 | 0.3287 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 92.98 | 84.90 | 11435 | 7257 | 1.5756 | 1.1468 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 94.68 | 84.90 | 2 | 7000 | 0.0003 | -0.4450 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 94.68 | 84.90 | 5661 | 7000 | 0.8087 | 0.9344 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 94.68 | 84.90 | 428 | 7000 | 0.0611 | 0.2893 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 94.68 | 84.90 | 11758 | 7000 | 1.6796 | 1.1697 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 2.66 | 84.90 | 574 | 285 | 2.0088 | 1.9789 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 2.66 | 84.90 | 569 | 285 | 1.9913 | 1.9640 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 4.36 | 84.90 | 641 | 322 | 1.9872 | 1.8569 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 4.36 | 84.90 | 656 | 322 | 2.0337 | 1.8914 | MN20160318_Q02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 6.06 | 84.90 | 715 | 365 | 1.9565 | 1.7507 | MN20160318_Q02 | C03 |